Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Active not recruiting 2 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 18 INDUSTRY 2 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Specimen Handling 39 Magnetic Resonance Spectroscopy 30 Carboplatin 14 Biopsy 14 Radiation 13 Cyclophosphamide 13 Radiotherapy 11 daratumumab 10 Vincristine 10 Dexamethasone 10 Surgical Procedures, Operative 9 Etoposide 9 Lenalidomide 8 X-Rays 7 Observation 7 Leucovorin 7 Irinotecan 7 Doxorubicin 7 Cisplatin 7 durvalumab 6 dexamethasone acetate 6 dexamethasone 21-phosphate 6 auricularum 6 Watchful Waiting 6 Radiosurgery 6 Docetaxel 6 Calcium Dobesilate 6 pembrolizumab 5 Stem Cell Transplantation 5 Standard of Care 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NETWORK × Dasatinib × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡